Cardiac Stem Cell Therapy Shows Promise for Regenerating Heart Muscle After Attack
Small trial tests safety of injecting patients' own cardiac stem cells to regrow dead heart tissue and restore function.
20 articles
Small trial tests safety of injecting patients' own cardiac stem cells to regrow dead heart tissue and restore function.
115-patient trial tested CardioCell stem cell treatment against placebo for chronic heart failure patients with promising regenerative approach.
Researchers tested injecting cardiac stem cells directly into heart arteries after heart attacks to promote healing and regeneration.
Researchers tested whether stem cells from healthy hearts could help repair damage in heart attack patients, offering hope for cardiac regeneration.
Large trial tests umbilical cord stem cells to prevent heart failure in heart attack patients with reduced heart function.
Clinical trial tested whether bone marrow stem cells could improve heart function beyond standard bypass surgery alone.
Completed study tested regenerative cardiac therapy in 105 heart attack patients, comparing stem cell treatment to placebo controls.
Researchers tested a novel stem cell therapy using umbilical cord cells on a pericardial matrix to repair heart tissue after heart attacks.
CRISPR gene therapy shows promise for curing genetic heart diseases like high cholesterol and amyloidosis with one-time treatments.
CAR-M2 therapy successfully reversed kidney scarring in lab studies by eliminating harmful endothelial cells and promoting healing.
Scientists discover how damaged heart cells transform into new blood vessels, potentially revolutionizing heart failure treatment.
A 2025 review maps the molecular drivers of cardiac aging and evaluates drugs, CRISPR, stem cells, and lifestyle as countermeasures.
A new review examines how drugs that clear senescent cells could transform treatment of age-related cardiovascular disease.
Researchers discovered specific cell markers that predict which leukemia patients will achieve lasting remission from CAR-T therapy.
UC San Diego scientists developed an injectable hydrogel that travels the bloodstream to reduce inflammation and regenerate damaged heart tissue.
Breakthrough study shows one epigenetic factor can transform cardiac fibroblasts into heart muscle cells, improving function after myocardial infarction.
Revolutionary gene-editing technology CRISPR becomes available outside the US, offering new hope for treating genetic diseases worldwide.
Scientists discover how to enhance cancer immunotherapy by converting tumor-supporting immune cells into tumor-fighting ones.
New editorial highlights advances in using stents to treat post-thrombotic syndrome, a chronic complication of blood clots.
New research reveals potential cancer risks following advanced CAR T-cell immunotherapy treatments.